Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Antimalarial Activity of DB289 in Volunteers Challenged With Plasmodium Falciparum

NCT00408369 is registered in ClinicalTrials.gov with Immtech Pharmaceuticals, Inc as lead sponsor.

NCT NCT00408369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00408369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Antimalarial Activity of DB289 in Volunteers Challenged With Plasmodium Falciparum
Lead sponsor
Immtech Pharmaceuticals, Inc
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2006
Completion date
November 30, 2007
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prophylactic activity against malaria